Published: 7 April 2016
Author(s): Robert Ekart, Radovan Hojs
Issue: April 2016
Section: Review Article

Obesity is a chronic disease that is increasingly prevalent around the world and is a well-recognized risk factor for type 2 diabetes and hypertension, leading causes of end-stage renal disease (ESRD). The obese diabetic patient with ESRD is a challenge for the nephrologist with regard to the type of renal replacement therapy that should be suggested and offered to the patient. There is no evidence that either peritoneal dialysis or hemodialysis is contraindicated in obese ESRD patients. In the literature, we can find a discrepancy in the impact of obesity on mortality among hemodialysis vs.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.